NRx Pharmaceuticals, Inc. (NRXP) Reports In-Line Q3 EPS

NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) reported Q3 EPS of ($0.14), in-line with the analyst estimate of ($0.14).

For earnings history and earnings-related data on NRx Pharmaceuticals, Inc. (NRXP) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Carnival shares drop despite earnings beat on weak guidance
• Zeta Surgical begins TMS navigation treatments at Hope Therapeutics clinics